Phuong N. Huynh

Array ( [id] => 8853134 [patent_doc_number] => 20130142810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'USE OF THE COMBINATION OF SEMAPHORIN-4D INHIBITORY MOLECULES AND VEGF INHIBITORY MOLECULES TO INHIBIT ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 13/707299 [patent_app_country] => US [patent_app_date] => 2012-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20483 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13707299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8853121 [patent_doc_number] => 20130142796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'TREATMENT FOR ANGIOGENIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/705983 [patent_app_country] => US [patent_app_date] => 2012-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4660 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13705983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10621684 [patent_doc_number] => 09340621 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-17 [patent_title] => 'Binding molecules for BCMA and CD3' [patent_app_type] => utility [patent_app_number] => 13/678247 [patent_app_country] => US [patent_app_date] => 2012-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 37722 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 3105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13678247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10945817 [patent_doc_number] => 20140348837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'BINDING MOLECULES FOR BCMA AND CD3' [patent_app_type] => utility [patent_app_number] => 14/358520 [patent_app_country] => US [patent_app_date] => 2012-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 71466 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16290133 [patent_doc_number] => 10766969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-08 [patent_title] => Binding molecules for BCMA and CD3 [patent_app_type] => utility [patent_app_number] => 14/358511 [patent_app_country] => US [patent_app_date] => 2012-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 44755 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 1002 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8883582 [patent_doc_number] => 20130156766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'TREATMENT OF DRY AGE RELATED MACULAR DEGENERATION' [patent_app_type] => utility [patent_app_number] => 13/677646 [patent_app_country] => US [patent_app_date] => 2012-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6102 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13677646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10115793 [patent_doc_number] => 09150664 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-06 [patent_title] => 'Binding molecules for BCMA and CD3' [patent_app_type] => utility [patent_app_number] => 13/678264 [patent_app_country] => US [patent_app_date] => 2012-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 25 [patent_no_of_words] => 57052 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1251 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13678264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8721442 [patent_doc_number] => 20130072659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites' [patent_app_type] => utility [patent_app_number] => 13/670790 [patent_app_country] => US [patent_app_date] => 2012-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16649 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13670790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9785218 [patent_doc_number] => 20140302038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-09 [patent_title] => 'MULTISPECIFIC AND MULTIVALENT BINDING PROTEINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/356434 [patent_app_country] => US [patent_app_date] => 2012-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 38511 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 53 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14356434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8732614 [patent_doc_number] => 20130078183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-28 [patent_title] => 'Multiple Signaling Pathways Induced by Hexavalent, Monospecific and Bispecific Antibodies for Enhanced Toxicity to B-Cell Lymphomas and Other Diseases' [patent_app_type] => utility [patent_app_number] => 13/668794 [patent_app_country] => US [patent_app_date] => 2012-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 41195 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13668794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11212013 [patent_doc_number] => 09441042 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-13 [patent_title] => 'Anti-KDR antibodies and methods of use' [patent_app_type] => utility [patent_app_number] => 14/356120 [patent_app_country] => US [patent_app_date] => 2012-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 31393 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14356120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14551217 [patent_doc_number] => 10344050 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-09 [patent_title] => Production of heterodimeric proteins [patent_app_type] => utility [patent_app_number] => 14/353962 [patent_app_country] => US [patent_app_date] => 2012-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 115 [patent_figures_cnt] => 191 [patent_no_of_words] => 70534 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 255 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14353962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8697807 [patent_doc_number] => 20130059816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASE' [patent_app_type] => utility [patent_app_number] => 13/659589 [patent_app_country] => US [patent_app_date] => 2012-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 91 [patent_figures_cnt] => 91 [patent_no_of_words] => 124842 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13659589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9950543 [patent_doc_number] => 08999325 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-07 [patent_title] => 'Treatment of ocular disease' [patent_app_type] => utility [patent_app_number] => 13/652154 [patent_app_country] => US [patent_app_date] => 2012-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15042 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13652154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8755246 [patent_doc_number] => 20130089551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'TREATMENT OF PULMONARY EDEMA' [patent_app_type] => utility [patent_app_number] => 13/646551 [patent_app_country] => US [patent_app_date] => 2012-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18086 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13646551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8659032 [patent_doc_number] => 20130039861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'Dye Conjugated Peptides for Fluorescent Imaging' [patent_app_type] => utility [patent_app_number] => 13/633577 [patent_app_country] => US [patent_app_date] => 2012-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 30157 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13633577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15483233 [patent_doc_number] => 10556949 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-11 [patent_title] => Antigen-binding molecule inducing immune response to target antigen [patent_app_type] => utility [patent_app_number] => 14/347448 [patent_app_country] => US [patent_app_date] => 2012-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 86990 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14347448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10932069 [patent_doc_number] => 20140335089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-13 [patent_title] => 'ANTIGEN-BINDING MOLECULE FOR PROMOTING ELIMINATION OF ANTIGENS' [patent_app_type] => utility [patent_app_number] => 14/347321 [patent_app_country] => US [patent_app_date] => 2012-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 81 [patent_figures_cnt] => 81 [patent_no_of_words] => 145519 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14347321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17044947 [patent_doc_number] => 11098115 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-24 [patent_title] => Multi-specific binding molecules targeting aberrant cells [patent_app_type] => utility [patent_app_number] => 14/348465 [patent_app_country] => US [patent_app_date] => 2012-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 13873 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14348465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9670453 [patent_doc_number] => 20140234316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'VACCIBODIES TARGETED TO CROSS-PRESENTING DENDRITIC CELLS' [patent_app_type] => utility [patent_app_number] => 14/346182 [patent_app_country] => US [patent_app_date] => 2012-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11270 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346182 [rel_patent_id] =>[rel_patent_doc_number] =>)